Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.All Scholarly Works
Document TypeArticle, Peer-reviewed
AbstractPubertal gynecomastia is thought to result from transient imbalances between estrogen and androgen concentrations. Anastrozole (ARIMIDEX), a potent and selective aromatase inhibitor, decreases estrogen and increases testosterone concentrations in pubertal
Citation InformationJ Clin Endocrinol Metab 2004 Sep;89(9):4428-33.